top of page

OUR SERVICES

Corporate Strategy​

Strategic advice for BioTech, TechBio, MedTech, HealthTech and SpaceTech companies on matters related to overall corporate strategy including:

  • Company Formation (Incorporation)

  • Business Plan & Go-To-Market Strategy

  • 10-Year Financial Models/Financial Estimates (Market Sizing, OPEX estimates, and P&L projections)

  • Structure Building (Workforce Plan, Identification and Engagement of FTEs, or 3rd party consultants/contractors, fractional leadership.

  • Patent/IP Strategy and execution.

  • Pricing and Market Access considerations.

  • Legal & Transactional Strategy and Support:

    • Founders’ Agreements, Board Member Agreements (BOD/SAB), Employment Agreements,

    • Consulting Agreements, Equity Incentive Plans and Option Agreements, NDAs and IP Assignment Agreements,

    • Collaboration and Sponsored Research Agreements

  • We have expertise in US investor-readiness and “soft-landing” for ex-US start-up

Corporate Strategy
AT the LAb

R&D Strategy and Support​

We have recently brought In-house some key Regulatory and R&D Experts who will provide Strategic advice for Biotech and MedTech companies on matters related to R&D, Quality, Engineering, Manufacturing, Pharmacology, CMC and Regulatory strategy including:

  • R&D Strategy and Support: IND gap analysis and roadmap (IND-enabling studies)

  • Pre-Clinical and Clinical Development

    • In-Vitro and bench testing. 

    • Pre-clinical/clinical development strategy and executional support. 

  • Regulatory strategy and support for IND filing, FDA meetings and other Regulatory affairs.

Investor-Readiness​

Assistance for Founders/CEOs of Early-stage companies to prepare for Pre-Seed/Seed Rounds, Angel/Early VC pitches:

  • Financing considerations/Use of Funds (based on Financial Estimates)

  • Exit scenarios/Strategic Deals: define the potential structure of a strategic deals like Paid Pilots, co-development deals and/or Licensing deals (upfront vs milestones and royalties). 

  • PITCH DECK creation or "polishing".

  • Executive Summary/One-Pager.

  • Investment Memo.

  • Data Room stocked with Due Diligence materials.

  • PRACTICE: conduct Pitch Practice sessions with Q&A simulating pitches to different kinds of investors (Angels vs. a Life Sciences investor) and potential Strategic Partner (BioPharma Company)

Fund Raising (Seed/Series A/Series B)
Commercial Planning and Geographical Footprint

Commercial Planning and Geographical Footprint 

​

Customized effective decision-making tools to help Biotech companies build a solid geographical footprint and develop the best strategy for the successful global launch:

  • Country prioritization and Launch Cadence

  • US "soft-landing" for Ex-US startups.

  • Business Opportunity Sizing (Patient-based country-specific revenue models)

  • Comprehensive Product Launch Plans, (deep expertise in rare disease/orphan drugs, Cell and Gene Therapy and other Specialty Therapeutics).

  • Go-To-Market Model design and assistance for successful execution.

  • Identification, selection and engagement of local team members or regional partners. 

©2025 Bio Strategy Advisors, LLC.. All Rights Reserved.

bottom of page